GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $476,000 | -49.5% | 17,500 | 0.0% | 0.01% | -50.0% |
| Q3 2022 | $942,000 | +34.2% | 17,500 | +0.6% | 0.02% | +45.5% |
| Q2 2022 | $702,000 | -33.8% | 17,400 | +8.8% | 0.01% | -21.4% |
| Q1 2022 | $1,060,000 | -35.0% | 16,000 | -1.8% | 0.01% | -30.0% |
| Q4 2021 | $1,630,000 | -20.0% | 16,300 | 0.0% | 0.02% | -28.6% |
| Q3 2021 | $2,038,000 | -4.0% | 16,300 | -4.7% | 0.03% | +3.7% |
| Q2 2021 | $2,123,000 | -11.9% | 17,100 | +8.2% | 0.03% | -20.6% |
| Q1 2021 | $2,411,000 | +13.4% | 15,800 | -4.2% | 0.03% | +13.3% |
| Q4 2020 | $2,126,000 | +32.0% | 16,500 | +14.6% | 0.03% | +11.1% |
| Q3 2020 | $1,610,000 | +40.7% | 14,400 | +2.1% | 0.03% | +28.6% |
| Q2 2020 | $1,144,000 | +131.6% | 14,100 | +98.6% | 0.02% | +90.9% |
| Q1 2020 | $494,000 | -11.0% | 7,100 | 0.0% | 0.01% | +10.0% |
| Q4 2019 | $555,000 | +25.9% | 7,100 | +2.9% | 0.01% | +25.0% |
| Q3 2019 | $441,000 | – | 6,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |